Kestra Advisory Services, LLC Dynavax Technologies Corp Transaction History

Kestra Advisory Services, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$7.45 - $12.83 $102,996 - $177,374	-13,825 Closed	0 $0
Q1 2022 Apr 26, 2022	SELL	$9.75 - $14.44 $27,787 - $41,154	-2,850 Reduced 17.09%	13,825 $149,000
Q4 2021 Jan 20, 2022	SELL	$13.17 - $20.94 $2,304 - $3,664	-175 Reduced 1.04%	16,675 $234,000
Q3 2021 Oct 19, 2021	BUY	$9.16 - $19.83 $49,006 - $106,090	5,350 Added 46.52%	16,850 $323,000
Q1 2021 May 10, 2021	SELL	$4.57 - $11.18 $31,336 - $76,661	-6,857 Reduced 37.35%	11,500 $113,000

Q4 2020 Jan 20, 2021	BUY	$3.73 - $5.6 $26,695 - $40,079	7,157 Added 63.9%	18,357 $90 Million
Q3 2020 Nov 12, 2020	BUY	$4.32 - $11.7 $48,384 - $131,039	11,200 New	11,200 $48 Million

269

132M

326K

758K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.42B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Kestra Advisory Services, LLC with notifications on news.